Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Francisco E. Vera-Badillo"'
Publikováno v:
European Urology Open Science, Vol 30, Iss , Pp 44-46 (2021)
Externí odkaz:
https://doaj.org/article/3abbba77c7154f59a5711924eb2974fb
Autor:
Sidra Khalid, Bassam Mohammed Basulaiman, Jeffrey Emack, Christopher M. Booth, Ignacio Duran, Andrew G. Robinson, David Berman, Martin Smoragiewicz, Eitan Amir, Francisco E. Vera-Badillo
Publikováno v:
European Urology Open Science, Vol 21, Iss , Pp 61-68 (2020)
Background: Fibroblast growth factor receptor 3 (FGFR3) mutations have been implicated in urothelial tumorigenesis. FGFR3 inhibitors are being explored in clinical trials. Objective: We aimed to study the association between FGFR3 mutations and survi
Externí odkaz:
https://doaj.org/article/97a165ed87b24c6d964a86fb6984384a
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/9ca555b68da44e4db586f97bd10de91c
Autor:
Eitan Amir, Ian F. Tannock, Alberto Ocaña, Boštjan Šeruga, Thomas Hermanns, Francisco E. Vera-Badillo, Mustafa Al-Mubarak, Mairéad G. McNamara, Olga Ace, Arnoud J. Templeton
PDF file - 233K, Search strategies. Supplementary Figure 1. Funnel plot of hazard ratio for overall survival for high neutrophil-to-lymphocyte ratio (horizontal axis) and the standard error for the hazard ratio (vertical axis). Supplementary Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c7befdd22f5dcde0118826ca1d9a5b
https://doi.org/10.1158/1055-9965.22436530
https://doi.org/10.1158/1055-9965.22436530
Autor:
Eitan Amir, Ian F. Tannock, Alberto Ocaña, Boštjan Šeruga, Thomas Hermanns, Francisco E. Vera-Badillo, Mustafa Al-Mubarak, Mairéad G. McNamara, Olga Ace, Arnoud J. Templeton
Background: Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor prognosis in several malignancies. Here, we quantify the prognostic impact of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed6fc0ee09afdc5e76043bf45cd8616
https://doi.org/10.1158/1055-9965.c.6515458
https://doi.org/10.1158/1055-9965.c.6515458
Autor:
Phillipe Joubert, Anil A. Joy, M. Mates, Ming-Sound Tsao, Glenwood D. Goss, Natasha B. Leighl, Keyue Ding, Normand Blais, Swati Kulkarni, Janet Dancey, Punam Rana, Scott A. Laurie, Martin R. Stockler, Penelope A. Bradbury, Sunil Yadav, Francisco E. Vera-Badillo, David M. Hwang, Craig Underhill, Christopher Lee, Andrea Hiltz, Brett G.M. Hughes
Publikováno v:
Journal of Thoracic Oncology. 17:434-445
First-line therapy for patients with metastatic NSCLC includes checkpoint inhibitor monotherapy, dual checkpoint inhibition, or combination with chemotherapy. We compared outcomes with combination chemoimmunotherapy versus dual checkpoint inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712a6e8a40cadfaf1eb9cab8968be679
https://doi.org/10.1016/j.jtho.2021.10.023
https://doi.org/10.1016/j.jtho.2021.10.023
Publikováno v:
Urology. 157:8-14
Objective To define the impact of first-line dual therapy involving immune checkpoint inhibitors (ICI) on survival outcomes in patients with advanced renal cell carcinoma (aRCC) of International Metastatic RCC Database Consortium favourable-risk. Mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845297a8516df74df508a2f7aa80a208
https://doi.org/10.1016/j.urology.2021.08.023
https://doi.org/10.1016/j.urology.2021.08.023
Autor:
Stephen Begbie, Wendy R. Parulekar, Scott North, Francis Parnis, Alvin Tan, David Pook, John McCaffrey, Xanthi Coskinas, Thean Hsiang Tan, M. Neil Reaume, Scott Williams, Francisco E. Vera-Badillo, Alastair Thomson, Emily Tu, Shahneen Sandhu, Alison Yan Zhang, Andrew J. Martin, Anthony M. Joshua, Lisa G. Horvath, Nicola Jane Lawrence, Margaret McJannett, Wendy Hague, Martin R. Stockler, Ian D. Davis, Christopher Sweeney, Robert Zielinski, Ray McDermott, Mark Frydenberg, Simon Chowdhury, Gavin Marx, Kim N. Chi, Sonia Yip
Publikováno v:
European Urology. 80:275-279
Men who initially present with localized prostate cancer and later develop metachronous metastases have a better prognosis than men with de novo metastatic disease and often have a low burden of disease on conventional imaging. Some have disease amen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c89e5cd5827a78e84a6994cb6b6b50
https://doi.org/10.1016/j.eururo.2021.05.016
https://doi.org/10.1016/j.eururo.2021.05.016
Autor:
Francisco E. Vera Badillo
Publikováno v:
Can Urol Assoc J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e12d0362ea47cfa3a728dc833af4fc
https://pubmed.ncbi.nlm.nih.gov/36240329
https://pubmed.ncbi.nlm.nih.gov/36240329
Autor:
Rebecca J. Deyell, Shantanu Banerji, Andrea J MacNeill, Alannah Smrke, Deanna McLeod, Francisco E. Vera-Badillo, Jonathan Noujaim, Albiruni Ryan Abdul Razak, Christine E. Simmons
Publikováno v:
International Journal of Cancer. 149:1691-1704
Malignant sarcomas are rare accounting for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34adffe57518975292a1c4e5d73ecd1e
https://doi.org/10.1002/ijc.33723
https://doi.org/10.1002/ijc.33723